RadNet Reports Record Q2 Revenue
(NASDAQ:RDNT) reported its Q2 2025 results on Aug. 11, 2025, posting record revenue of $498.2 million, up 8.4% year-over-year and record adjusted EBITDA (non-GAAP) of $81.2 million, up 12.3% YoY. Management raised full-year 2025 guidance for both revenue and adjusted EBITDA (non-GAAP) and highlighted margin improvement from tech-enabled productivity gains, recent acquisitions, and AI rollouts integrated across core and digital health operations.
Record quarterly adjusted EBITDA margin (non-GAAP) improved by 57 basis points year-over-year to 16.3%, propelled by rapid adoption of TechLive remote scanning and AI-driven workflow upgrades. The pilot program for TechLive in New York reduced MRI room closures by 42%, with more than 300 imaging systems now connected and company-wide integration on track for early 2026. Capital allocation continues to favor high-return investments in advanced imaging capacity and clinical workflow technologies.
The successful scaling of remote scanning has rapidly unlocked latent capacity with limited capital investment, setting the stage for continued operating leverage and offering a defensible solution to industry-wide technologist shortages.
Source Fool.com
Radnet Inc. Stock
We see a rather positive sentiment for Radnet Inc. with 17 Buy predictions and 1 Sell predictions.
As a result the target price of 70 € shows a slightly positive potential of 11.11% compared to the current price of 63.0 € for Radnet Inc..
